Literature DB >> 20853141

Tissue binding patterns and in vitro effects of Campylobacter jejuni DNA-binding protein from starved cells.

Hua Piao1, Motozumi Minohara, Nobutoshi Kawamura, Wei Li, Takuya Matsushita, Ryo Yamasaki, Yoshimitsu Mizunoe, Jun-Ichi Kira.   

Abstract

Campylobacter jejuni (C. jejuni) is frequently associated with axonal Guillain-Barré syndrome (GBS). We reported that C. jejuni DNA-binding protein from starved cells (C-Dps) binds to and damages myelinated nerves in vivo. We studied the binding patterns of C-Dps to nervous tissues and its in vitro effects on neural cells. Immunohistochemically, C-Dps labeled the nodes of Ranvier, the outermost parts of internodal myelin and the basement membrane in the peripheral nerves, and neurons and myelin in the central nervous tissues. Its binding was blocked by sulfatide. C-Dps bound to the cell surfaces of nerve growth factor (NGF)-treated PC12 cells leading to dose-dependent LDH release, which was inhibited by either heat-denaturation of C-Dps or coincubation with an anti-C-Dps mAb. However, its binding to the surfaces of cultured NSC34 cells, S16 cells, or dorsal root ganglion cells, did not induce cytotoxicity. These findings suggest a possible involvement of C-Dps in C. jejuni-related GBS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20853141     DOI: 10.1007/s11064-010-0263-7

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  43 in total

1.  A myelin galactolipid, sulfatide, is essential for maintenance of ion channels on myelinated axon but not essential for initial cluster formation.

Authors:  Tomoko Ishibashi; Jeffrey L Dupree; Kazuhiro Ikenaka; Yukie Hirahara; Koichi Honke; Elior Peles; Brian Popko; Kinuko Suzuki; Hitoo Nishino; Hiroko Baba
Journal:  J Neurosci       Date:  2002-08-01       Impact factor: 6.167

2.  Anti-sulfatide antibodies in HIV-infected individuals with sensory neuropathy.

Authors:  G Lopate; A Pestronk; S Evans; L Li; D Clifford
Journal:  Neurology       Date:  2005-05-10       Impact factor: 9.910

Review 3.  Mechanisms of action of anti-GM1 and anti-GQ1b ganglioside antibodies in Guillain-Barré syndrome.

Authors:  H J Willison; G O'Hanlon; G Paterson; C P O'Leary; J Veitch; G Wilson; M Roberts; T Tang; A Vincent
Journal:  J Infect Dis       Date:  1997-12       Impact factor: 5.226

4.  Antibodies to sulfatide and to chondroitin sulfate C in patients with chronic sensory neuropathy.

Authors:  R Nemni; R Fazio; A Quattrini; I Lorenzetti; D Mamoli; N Canal
Journal:  J Neuroimmunol       Date:  1993-03       Impact factor: 3.478

Review 5.  Antiglycolipid antibodies in Guillain-Barré syndrome and related diseases: review of clinical features and antibody specificities.

Authors:  Toshio Ariga; Robert K Yu
Journal:  J Neurosci Res       Date:  2005-04-01       Impact factor: 4.164

6.  Antibodies against GM1 ganglioside affect K+ and Na+ currents in isolated rat myelinated nerve fibers.

Authors:  T Takigawa; H Yasuda; R Kikkawa; Y Shigeta; T Saida; H Kitasato
Journal:  Ann Neurol       Date:  1995-04       Impact factor: 10.422

7.  Neuromuscular blockade by IgG antibodies from patients with Guillain-Barré syndrome: a macro-patch-clamp study.

Authors:  B Buchwald; K V Toyka; J Zielasek; A Weishaupt; S Schweiger; J Dudel
Journal:  Ann Neurol       Date:  1998-12       Impact factor: 10.422

8.  Hyperreflexia in axonal Guillain-Barré syndrome subsequent to Campylobacter jejuni enteritis.

Authors:  Satoshi Kuwabara; Miho Nakata; Jia-Ying Sung; Masahiro Mori; Naoko Kato; Takamichi Hattori; Michiaki Koga; Nobuhiro Yuki
Journal:  J Neurol Sci       Date:  2002-07-15       Impact factor: 3.181

9.  Biochemical and cellular properties of three immortalized Schwann cell lines expressing different levels of the myelin-associated glycoprotein.

Authors:  K Toda; J A Small; S Goda; R H Quarles
Journal:  J Neurochem       Date:  1994-11       Impact factor: 5.372

10.  Effects on axonal conduction of anti-ganglioside sera and sera from patients with Guillain-Barré syndrome.

Authors:  A Dilley; N A Gregson; R D M Hadden; K J Smith
Journal:  J Neuroimmunol       Date:  2003-06       Impact factor: 3.478

View more
  5 in total

Review 1.  Role of sulfatide in normal and pathological cells and tissues.

Authors:  Tadanobu Takahashi; Takashi Suzuki
Journal:  J Lipid Res       Date:  2012-05-22       Impact factor: 5.922

Review 2.  Change is good: variations in common biological mechanisms in the epsilonproteobacterial genera Campylobacter and Helicobacter.

Authors:  Jeremy J Gilbreath; William L Cody; D Scott Merrell; David R Hendrixson
Journal:  Microbiol Mol Biol Rev       Date:  2011-03       Impact factor: 11.056

3.  A Campylobacter jejuni Dps homolog has a role in intracellular survival and in the development of campylobacterosis in neonate piglets.

Authors:  James R Theoret; Kerry K Cooper; Robert D Glock; Lynn A Joens
Journal:  Foodborne Pathog Dis       Date:  2011-08-21       Impact factor: 3.171

Review 4.  Guillain-Barré syndrome, transverse myelitis and infectious diseases.

Authors:  Yhojan Rodríguez; Manuel Rojas; Yovana Pacheco; Yeny Acosta-Ampudia; Carolina Ramírez-Santana; Diana M Monsalve; M Eric Gershwin; Juan-Manuel Anaya
Journal:  Cell Mol Immunol       Date:  2018-01-29       Impact factor: 11.530

5.  Clostridium Perfringens Epsilon Toxin Binds to Membrane Lipids and Its Cytotoxic Action Depends on Sulfatide.

Authors:  Carles Gil; Jonatan Dorca-Arévalo; Juan Blasi
Journal:  PLoS One       Date:  2015-10-09       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.